Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities.

World journal of gastroenterology - 14 May 2014

Shaker Mina, Tabbaa Adam, Albeldawi Mazen, Alkhouri Naim

Abstract excerpt

Nonalcoholic fatty liver disease (NAFLD) is becoming rapidly one of the most common indications for orthotopic liver transplantation in the world. Development of graft steatosis is a significant problem during the post-transplant course, which may happen as a recurrence of pre-existing disease or de novo NAFLD. There are different risk factors that might play a role in development of graft steatosis including...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Graft Survival
Share to Liver Transplantation
Share to Non-alcoholic Fatty Liver Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Postoperative Complications

Share to Recurrence

Share to Risk Factors

Share to Time Factors

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 24833862
DOI: 10.3748/wjg.v20.i18.5320
PMCID: PMC4017047

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities.PMID 24833862Read ↗

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read ↗

Obesity and the liver: nonalcoholic fatty liver disease.Semantic proximity Read ↗

Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Non-alcoholic fatty liver disease.Semantic proximity Read ↗

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk FactorsSemantic proximity Read ↗

Recent advances in understanding and managing non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.Semantic proximity Read ↗

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.Semantic proximity Read ↗

Present and future therapeutic strategies in non-alcoholic fatty liver disease.Semantic proximity Read ↗

Natural History of NAFLDSemantic proximity Read ↗

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and BeyondSemantic proximity Read ↗

Nonalcoholic fatty liver disease: a challenge for pediatricians.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.